Would you consider chemoradiation to the primary in a patient with resectable pancreatic cancer s/p neoadjuvant chemotherapy found to have single liver metastasis on re-staging?   

If so, what dose and fractionation? 



Answer from: Radiation Oncologist at Academic Institution